首页> 美国卫生研究院文献>Virology Journal >Performance and diagnostic usefulness of commercially available enzyme linked immunosorbent assay and rapid kits for detection of HIV HBV and HCV in India
【2h】

Performance and diagnostic usefulness of commercially available enzyme linked immunosorbent assay and rapid kits for detection of HIV HBV and HCV in India

机译:在印度可用于检测HIVHBV和HCV的酶联免疫吸附测定和快速试剂盒的性能和诊断实用性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHIV, HBV and HCV pose a major public health problem throughout the world. Detection of infection markers for these agents is a major challenge for testing laboratories in a resource poor setting. As blood transfusion is an important activity saving millions of live every year, it also carries a risk of transfusion transmissible infections caused by these fatal blood borne pathogens if the quality of testing is compromised. Conventional ELISA is regarded as the mostly used screening technique but due to limitations like high cost, unavailability in many blood banks and testing sites, involvement of costly instruments, time taking nature and requirement of highly skilled personnel for interpretation, rapid tests are gaining more importance and warrants comparison of performance.
机译:背景技术HIV,HBV和HCV构成了世界范围内的主要公共卫生问题。在资源匮乏的环境中,检测这些试剂的感染标记是测试实验室的主要挑战。由于输血是一项重要活动,每年可挽救数百万人的生命,如果检测质量受到影响,输血还可能会传播由这些致命的血源性病原体引起的可传播感染。常规ELISA被认为是最常用的筛查技术,但是由于成本高,许多血库和检测点无法使用,昂贵的仪器的介入,花费时间的性质以及需要高技能人员进行解释的局限性,快速检测变得越来越重要并保证比较性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号